As various nations consider application of international ABS requirements to GSD, research organizations and synthetic biology companies should closely follow these developments to determine how they may impact their use of GSD. Moreover, those accessing GSD should consider, if possible, the extent to which unilateral ABS agreements requirements may govern their use of such information.
Learn more by reading the full article by Bruce Manheim, published by Genetic Engineering & Biotechnology News (GEN).
